Event News & Resources
New Publication: Evaluating Monoclonal Antibodies in Alzheimer’s Disease Research
We are pleased to announce the publication of our latest paper, “Evaluating the Efficacy of Monoclonal Antibodies Against a Bioactive Peptide Involved in Alzheimer’s Disease: A Methodological Approach.” The paper outlines a methodological framework for assessing...
Neuro-Bio attends the Global Mind Brain Health Summit at the University of Oxford
Recently, our Project Development Manager Bethany Watkinson and one of our Senior Scientists Sibah Hasan attended the Global Mind Brain Health Summit hosted by The Centre for Global Epilepsy at the University of Oxford. The event centered on 'Empowering...
Neuro-Bio visits Munich for the Brain-Nose Symposium, hosted by Noselab!
Our research scientists, Amy Lewis and Lois Glover, recently attended the Brain-Nose Symposium in Munich, hosted by Noselab. This two-day event offered exceptional insights into the brain-nose interface and highlighted how nasal secretions can be leveraged for a range...
Neuro-Bio’s CEO & Founder, Baroness Susan Greenfield attends DC Finance’s Global Family Office & High Net Worth Community 2025 London Conference
We’re delighted to share that our Founder and CEO, Baroness Susan Greenfield, attended and took part in a fireside chat on “The Evolution of Leadership with Business and Politics” at this year’s DC Finance's Global Family Office & High Net Worth Community 2025...
Meeting with Prof. Lorna Harries at the University of Exeter to review progress and plan next experiments
Last week, Neuro-Bio’s RNA-based therapies team met with Professor Lorna Harries at the University of Exeter to discuss project progress and plan future experiments. The meeting was highly productive, sparking new ideas and strengthening the collaboration between...
Our Office Manager Charles Monro attended the new opening of the reception area at UK Atomic Energy Authority
For those yet to see it, the space is looking fantastic! Attending these events is really important to us - they give us the opportunity to support the community, share ideas, and connect with colleagues across Culham Campus, as well as to share what we are doing at...
Neuro-Bio welcomes back Adam Khan
Adam has returned to Neuro-Bio as a Senior Scientist, after completing his MSc in Pharmacology at the University of Oxford. Since Adam was last at Neuro-Bio, he has performed radiotracer assays investigating drug interactions at the Blood-brain barrier. He has also...





